Work

Various Mechanisms Underlie Cytogenetic Refractoriness to Imatinib.

Year: 2004

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood.v104.11.2091.2091

Authors: Lucy Crossman, Michael Heinrich, Richard Press, Stephanie Willis, Michael Deininger, Brian Druker

Institution: Oregon Health & Science University

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2588704253

FWCI: 0.378

Cites:

Cited by: 2

Related to: 10